07:00 , Apr 23, 2012 |  BC Week In Review  |  Clinical News

Hematopoietic stem cell gene therapy regulatory update

European Commission granted Orphan Drug designation for the not-for-profit's autologous hematopoietic stem cell gene therapy to treat X-linked chronic granulomatous disease (CGD). The hematopoietic cells genetically modified with a lentiviral vector containing the cytochrome...